CLOV vs HYNE · rev $1.37B vs P/E 408, $121.8M cap
Clover Health Investments Corp (CLOV) versus Hoyne Bancorp, Inc. Common Stock (HYNE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Hoyne Bancorp, Inc. Common Stock (HYNE) is a banks - regional company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
HYNE does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. HYNE currently screens at market cap $121.8M and trailing P/E 408.5.
Not investment advice. Open the CLOV and HYNE stock pages for the full models.
Not investment advice.